The landscape of drug safety testing is undergoing a profound transformation, marked by the rapid ascent of New Approach Methodologies…
Read More

The landscape of drug safety testing is undergoing a profound transformation, marked by the rapid ascent of New Approach Methodologies…
Read More
In recent years, the landscape of drug safety testing has undergone a profound transformation, marked by the rapid acceleration of…
Read More
The US Food and Drug Administration (FDA) has unveiled its comprehensive final guidance for industry on collecting crucial post-marketing safety…
Read More
The top executive of the largest public hospital system in New York City has ignited a significant debate within the…
Read More
The rapid acceleration of New Approach Methodologies (NAMs) in drug safety testing has, for many, appeared to be a sudden…
Read More
The burgeoning telehealth industry, lauded for its potential to democratize healthcare access, is facing intensified scrutiny as companies push the…
Read More
The landscape of artificial intelligence is rapidly evolving, with a growing emphasis on "agentic" systems – AI entities capable of…
Read More
Eli Lilly has swiftly responded to concerns raised by the US Food and Drug Administration (FDA) regarding the long-term safety…
Read More
The US Food and Drug Administration (FDA) has issued draft guidance aimed at enhancing the safety assessment of genome editing…
Read More
New Orleans, LA – A groundbreaking Bayesian network meta-analysis presented at the American College of Cardiology (ACC) 75th Annual Scientific…
Read More